Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical pharmacological study of tofogliflozin in type 2 diabetes by kidney function
jRCT2080221532Phase 2
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of tofogliflozin in type 2 diabetes mellitus (T2DM), sponsored by Chugai Pharmaceutical Co., Ltd.
02
Drugs
tofogliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080221532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221532.